Answers are grounded in this paper and cite their sources.
Twenty‐four participants (15 men; 9 women) performed baseline testing (day 1) after following a standard unsupplemented diet. This was followed by the daily ingestion of a creatine formulation dietary loading sequence for 5 days (days 2–6, Phosphagen HP™ 5.25 g creatine mono‐hydrate (CR) 4‐ 33 g dextrose). Loading consisted of 4 servings of Phosphagen HP™ per day. On day 7, participants were randomly assigned to one of three double‐blind treatments administered 1 h before testing. During treatment, subjects were randomly fed: (a) 10 g of CR, (b) 80 g of dextrose, or (c) 10 g of CR + 80 g of dextrose. Variables evaluating the effectiveness of the different regimens included body mass, two 30‐s Wingate anaerobic performance power tests and measurement of serum creatine concentration 65 and 5 min before each trial. Plasma ammonia concentration was also measured 65 min before and 5 min after each trial. The results of this trial show a significant non‐placebo controlled effect for the pooled, group and gender data (P ≤ 0.05). Following 5 days of Phosphagen HP™ loading, significant pooled group mean changes were: (1) body mass (+1.08 kg), (2) anaerobic power (1st Wingate = + 1.28 kJ; 2nd Wingate 2 = (+1.92kJ), (3) serum creatine concentration 65 min prior to testing trials (+624.06 μmol · L−1) and (4) post‐test plasma ammonia concentration (—83.63 μmol · L−1). However, on day 7, in placebo group condition, no between group performance effects were noted following an acute 10 g oral bolus of CR 1 h prior to the exercise test. It is concluded that no performance benefit is due to acute ingestion of CR 1 h before exercise in CR loaded individuals.
No takes yet. Share an insight, caveat, or question.
Earnest et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: